Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Tel Aviv - Yafo
- Most recent report
- 6-K, filed Sep 4, 2026
- Filings on record
- 92 filings
- On EDGAR
- CIK 2029039
- Fiscal year ends
- December
- Filer status
- Non-accelerated filer, Emerging growth company
Financials 8 of 24
- 6-K Report a foreign issuer made public elsewhere Sep 4, 2026
- 6-K Report a foreign issuer made public elsewhere Aug 19, 2026
- 6-K Report a foreign issuer made public elsewhere Aug 17, 2026
- 6-K Report a foreign issuer made public elsewhere Jul 28, 2026
- 6-K Report a foreign issuer made public elsewhere Jun 9, 2026
- 6-K Report a foreign issuer made public elsewhere Mar 25, 2026
- 20-F Annual report, foreign issuer Mar 25, 2026
- 6-K Report a foreign issuer made public elsewhere Mar 16, 2026
Prospectuses and Registrations 8 of 9
- F-3 Sep 1, 2026
- POS AM Post-effective amendment to a registration Aug 19, 2026
- S-8 Registration statement for an employee plan May 26, 2026
- POS AM Post-effective amendment to a registration Mar 27, 2026
- F-1 Registration statement, foreign issuer Mar 2, 2026
- 424B4 Final prospectus for an offering Aug 14, 2025
- FWP Free writing prospectus Jul 30, 2025
- FWP Free writing prospectus Jul 28, 2025
Ownership 8 of 20
- SCHEDULE 13G/A Large holder reported a passive stake, amended Aug 14, 2026
- 3 Insider reported their initial holding Jul 31, 2026
- 4 Insider reported a trade Jul 29, 2026
- 4 Insider reported a trade Jun 22, 2026
- SCHEDULE 13G Large holder reported a passive stake May 15, 2026
- 4 Insider reported a trade Apr 22, 2026
- SCHEDULE 13G Large holder reported a passive stake Apr 7, 2026
- 4 Insider reported a trade Apr 1, 2026
Other 8 of 39
- EFFECT Notice that a registration became effective Aug 20, 2026
- EFFECT Notice that a registration became effective Mar 31, 2026
- EFFECT Notice that a registration became effective Mar 13, 2026
- CORRESP Reply to SEC staff Mar 11, 2026
- UPLOAD Comment letter from SEC staff Mar 6, 2026
- D Feb 25, 2026
- EFFECT Notice that a registration became effective Aug 12, 2025
- CERT Exchange certified a listing Aug 12, 2025
Everything here comes from Nasus Pharma Ltd's own filings on SEC EDGAR. The filing list is rechecked every hour.